Wegovy (semaglutide) is considered a safe and effective treatment for the conditions it’s approved to treat. Possible problems with long-term use include pancreatitis, gallbladder disease, and kidney ...

What Is Wegovy, and Why Does It Matter? Wegovy (semaglutide) is a prescription medicine that helps with weight loss and lowers the risk of heart problems and liver disease. The FDA has approved its ...

Wegovy (semaglutide) is a medicine used to help people lose weight and keep it off. It belongs to a group of drugs called glucagon-like peptide-1s (GLP-1s). If you have heart disease and are ...

Zepbound and Wegovy treat weight loss and weight management in adults with obesity or overweight. Both drugs are also approved to treat other conditions. These drugs are given as weekly injections, ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Wegovy (semaglutide) is a prescription injection approved to help with weight loss and reduce the risk of serious cardiovascular issues. You may wonder about the best way to store Wegovy and whether ...

The weight-loss drug Wegovy is now available in Australia. Wegovy is administered as a once-weekly injection and is approved specifically for weight management. It’s intended to be used in combination ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in GLP-1 ...

The mechanism of action of Wegovy (how it works) may vary depending on the indication(s) for which it is prescribed. Here is what experts know about Wegovy’s mechanism of action for its approved uses.

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...